Mawson Infrastructure Group Inc. — Director's Dealing 2021

Mar 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2021-03-09

Reporting Person: Rubini Jonathan Brian (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-09	Common Stock, par value $0.001 per share	P	10416667	$0.12	Acquired	17516715	Direct